Newsroom

カリフォルニア州サンカルロス--(BUSINESS WIRE)--（ビジネスワイヤ） -- ファーストインクラスとなるミエロイド細胞エンゲージャー治療薬を開発する非公開の臨床段階バイオテクノロジー企業であるドレン・バイオは、サノフィ（NASDAQ：SNY）と、さまざまな自己免疫疾患の治療を目的とした次世代B細胞枯渇療法の発見と開発に関する戦略的協業契約を締結したことを発表しました。 この新たな契約は、今年初めにサノフィがドレン・バイオの深部B細胞枯渇を目指すプログラムであるDR-0201を買収したことに続き、両社の既存の関係をさらに発展させるものです。DR-0201は現在SAR448501として知られており、進行中の2件の第1相試験で評価されています。これまでに強力なB細胞枯渇効果を示しており、自己免疫疾患の患者に持続的な治療不要の寛解をもたらす可能性があります。 「このたび拡大したドレン・バイオとの戦略的アライアンスは、免疫介在性疾患の患者に寛解をもたらし得る最高水準の治療法を開発するというサノフィの強いコミットメントを示すものです」と、サノフィのグローバル・セラピューティック・ヘ...

TORONTO--(BUSINESS WIRE)--Accord Financial Corp. (« Accord » ou la « société ») (TSX – ACD) a annoncé aujourd'hui, avoir conclu un accord avec son syndicat de prêteurs, concernant une prolongation à court terme de sa principale facilité de crédit (la « facilité bancaire ») du 15 décembre 2025 au 23 décembre 2025. Cette prolongation donnera à la société, plus de temps pour finaliser les discussions relatives à une modification de la facilité bancaire, qui prolongerait encore la date d'échéance j...

LONDON--(BUSINESS WIRE)--      DMO-TAS041/3603/003         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A206\25 16 December 2025   PRESS NOTICE   RESULT OF THE SALE BY AUCTION OF £4250 MILLION OF 4⅛% TREASURY GILT 2031The United Kingdom Debt Management Office ("DMO") announces that the auction of £4,250 million of 4⅛% Treasury Gilt 2031 (ISIN Code: GB00BVP99673) has been allocated as follows:(Note: all prices in this notice are quoted...

HANGZHOU, China--(BUSINESS WIRE)--Atom now has a strategic foothold in dual therapeutic areas of metabolism and cardiovascular diseases, strengthening its core competitive edge....

BASINGSTOKE, England--(BUSINESS WIRE)--Glory (TYO: 6457), a global and UK leader in cash automation solutions has announced that supermarket Waitrose has selected the company’s CI-100X solution to streamline and improve their back office cash management process in its stores across the UK. Glory is installing two hundred and eighty five CI-100X back office cash recycling devices in Waitrose stores with the rollout already underway. Glory's CI-100X solution offers enhanced flexibility, capabilit...

MUNICH--(BUSINESS WIRE)--Hexnode UEM, die Unternehmenssoftwaresparte von Mitsogo Inc., gibt bekannt, dass sie in fünf Berichten von IDC MarketScape: Worldwide Unified Endpoint Management Software Vendor Assessment aufgeführt ist. Die Auflistung enthält eine Bewertung der wichtigsten Anbieter auf dem Markt für Unified Endpoint Management. Hexnode als führendes Unternehmen ausgezeichnet, in „:IDC MarketScape: Worldwide Unified Endpoint Management Software for Apple Devices 2025/26 Vendor Assessme...

MENLO PARK, Californie--(BUSINESS WIRE)--Lightspeed Venture Partners (« Lightspeed ») a annoncé aujourd’hui la clôture d’un capital engagé de plus de 9 milliards USD répartis entre six véhicules distincts et hautement sélectifs, à savoir Lightspeed Venture Partners Fund XV-A (980 millions USD), Lightspeed Venture Partners Fund XV-B (1,2 milliard USD), Lightspeed Select VI (1,8 milliard USD) et Lightspeed Opportunity Fund III (3,3 milliards USD), ainsi que Lightspeed Co-Investment Fund I (600 mi...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Long Pond Capital, LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  ...

HANOI, Vietnam--(BUSINESS WIRE)--Nucleus Software’s FinnOne Neo® platform has provided an innovative solution for Military Joint Stock Commercial Bank’s management ecosystem....

HEIDELBERG, Germany--(BUSINESS WIRE)--Hummingbird Diagnostics GmbH, a pioneer in harnessing blood-based small RNAs for early disease detection and characterization, today announced the publication of a new study in Nature Communications Medicine introducing an Oxford Nanopore Technologies (ONT)-based method for detecting small RNA modifications in blood. The research demonstrates that direct small RNA sequencing can identify differential RNA methylation patterns associated with lung cancer, rep...